BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Discontinued (World)
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013  More...
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013  More...
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013  More...
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013  More...
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013  More...
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013  More...
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013  More...
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013  More...
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013  More...
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013  More...
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012  More...
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012  More...
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012  More...
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012  More...
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012  More...
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012  More...
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012  More...
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012  More...
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012  More...
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012  More...
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012  More...
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012  More...
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011  More...
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011  More...
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011  More...
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011  More...
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011  More...
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011  More...
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011  More...
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011  More...
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011  More...
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011  More...
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011  More...
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010  More...
Roche (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Decision to Discontinue Phase 3 Ocrelizumab Clinical Development Program in Patients with Rheumatoid Arthritis 5/19/2010  More...
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009  More...
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008  More...
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008  More...
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008  More...
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008  More...





 

//-->